Cargando…

Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis

Many malignancies show increased expression of the EGF receptor family member ErbB3 (HER3). ErbB3 binds beta-1 (HRGβ1), and forms a heterodimer with other ErbB family members, such as ErbB2 (HER2) or EGFR (HER1), enhancing phosphorylation of specific C terminal tyrosine residues and activation of do...

Descripción completa

Detalles Bibliográficos
Autores principales: Smirnova, Tatiana, Zhou, Zhen Ni, Flinn, Rory J., Wyckoff, Jeffrey, Boimel, Pamela J., Pozzuto, Maria, Coniglio, Salvatore J., Backer, Jonathan M., Bresnick, Anne R., Condeelis, John S., Hynes, Nancy E., Segall, Jeffrey E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469325/
https://www.ncbi.nlm.nih.gov/pubmed/21725367
http://dx.doi.org/10.1038/onc.2011.275
_version_ 1782246060248268800
author Smirnova, Tatiana
Zhou, Zhen Ni
Flinn, Rory J.
Wyckoff, Jeffrey
Boimel, Pamela J.
Pozzuto, Maria
Coniglio, Salvatore J.
Backer, Jonathan M.
Bresnick, Anne R.
Condeelis, John S.
Hynes, Nancy E.
Segall, Jeffrey E.
author_facet Smirnova, Tatiana
Zhou, Zhen Ni
Flinn, Rory J.
Wyckoff, Jeffrey
Boimel, Pamela J.
Pozzuto, Maria
Coniglio, Salvatore J.
Backer, Jonathan M.
Bresnick, Anne R.
Condeelis, John S.
Hynes, Nancy E.
Segall, Jeffrey E.
author_sort Smirnova, Tatiana
collection PubMed
description Many malignancies show increased expression of the EGF receptor family member ErbB3 (HER3). ErbB3 binds beta-1 (HRGβ1), and forms a heterodimer with other ErbB family members, such as ErbB2 (HER2) or EGFR (HER1), enhancing phosphorylation of specific C terminal tyrosine residues and activation of downstream signaling pathways. ErbB3 contains six YXXM motifs that bind the p85 subunit of PI3-kinase. Previous studies demonstrated that overexpression of ErbB3 in mammary tumor cells can significantly enhance chemotaxis to HRGβ1 and overall metastatic potential. We tested the hypothesis that ErbB3-mediated PI3-kinase signaling is critical for heregulin-induced motility, and therefore crucial for ErbB3-mediated invasion, intravasation and metastasis. The tyrosines in the six YXXM motifs on the ErbB3 C-terminus were replaced with phenylalanine. In contrast to overexpression of the wild-type ErbB3, overexpression of the mutant ErbB3 did not enhance chemotaxis towards HRGβ1 in vitro or in vivo. We also observed reduced tumor cell motility in the primary tumor by multiphoton microscopy, as well as a dramatically reduced ability of these cells to cross the endothelium and intravasate into the circulation. Moreover, while mutation of the ErbB3 C-terminus had no effect on tumor growth, it had a dramatic effect on spontaneous metastatic potential. Treatment with the PI3-kinase inhibitor PIK-75 similarly inhibited motility and invasion in vitro and in vivo. Our results indicate that stimulation of the early metastatic steps of motility and invasion by ErbB3 requires activation of the PI3-kinase pathway by the ErbB3 receptor.
format Online
Article
Text
id pubmed-3469325
institution National Center for Biotechnology Information
language English
publishDate 2011
record_format MEDLINE/PubMed
spelling pubmed-34693252012-10-11 Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis Smirnova, Tatiana Zhou, Zhen Ni Flinn, Rory J. Wyckoff, Jeffrey Boimel, Pamela J. Pozzuto, Maria Coniglio, Salvatore J. Backer, Jonathan M. Bresnick, Anne R. Condeelis, John S. Hynes, Nancy E. Segall, Jeffrey E. Oncogene Article Many malignancies show increased expression of the EGF receptor family member ErbB3 (HER3). ErbB3 binds beta-1 (HRGβ1), and forms a heterodimer with other ErbB family members, such as ErbB2 (HER2) or EGFR (HER1), enhancing phosphorylation of specific C terminal tyrosine residues and activation of downstream signaling pathways. ErbB3 contains six YXXM motifs that bind the p85 subunit of PI3-kinase. Previous studies demonstrated that overexpression of ErbB3 in mammary tumor cells can significantly enhance chemotaxis to HRGβ1 and overall metastatic potential. We tested the hypothesis that ErbB3-mediated PI3-kinase signaling is critical for heregulin-induced motility, and therefore crucial for ErbB3-mediated invasion, intravasation and metastasis. The tyrosines in the six YXXM motifs on the ErbB3 C-terminus were replaced with phenylalanine. In contrast to overexpression of the wild-type ErbB3, overexpression of the mutant ErbB3 did not enhance chemotaxis towards HRGβ1 in vitro or in vivo. We also observed reduced tumor cell motility in the primary tumor by multiphoton microscopy, as well as a dramatically reduced ability of these cells to cross the endothelium and intravasate into the circulation. Moreover, while mutation of the ErbB3 C-terminus had no effect on tumor growth, it had a dramatic effect on spontaneous metastatic potential. Treatment with the PI3-kinase inhibitor PIK-75 similarly inhibited motility and invasion in vitro and in vivo. Our results indicate that stimulation of the early metastatic steps of motility and invasion by ErbB3 requires activation of the PI3-kinase pathway by the ErbB3 receptor. 2011-07-04 2012-02-09 /pmc/articles/PMC3469325/ /pubmed/21725367 http://dx.doi.org/10.1038/onc.2011.275 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Smirnova, Tatiana
Zhou, Zhen Ni
Flinn, Rory J.
Wyckoff, Jeffrey
Boimel, Pamela J.
Pozzuto, Maria
Coniglio, Salvatore J.
Backer, Jonathan M.
Bresnick, Anne R.
Condeelis, John S.
Hynes, Nancy E.
Segall, Jeffrey E.
Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis
title Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis
title_full Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis
title_fullStr Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis
title_full_unstemmed Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis
title_short Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis
title_sort phosphoinositide 3-kinase signaling is critical for erbb3-driven breast cancer cell motility and metastasis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469325/
https://www.ncbi.nlm.nih.gov/pubmed/21725367
http://dx.doi.org/10.1038/onc.2011.275
work_keys_str_mv AT smirnovatatiana phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT zhouzhenni phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT flinnroryj phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT wyckoffjeffrey phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT boimelpamelaj phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT pozzutomaria phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT conigliosalvatorej phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT backerjonathanm phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT bresnickanner phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT condeelisjohns phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT hynesnancye phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis
AT segalljeffreye phosphoinositide3kinasesignalingiscriticalforerbb3drivenbreastcancercellmotilityandmetastasis